These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 25582240
1. The future of red blood cell alloimmunization risk reduction. Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AA. Transfusion; 2015 Jan; 55(1):222-4. PubMed ID: 25582240 [No Abstract] [Full Text] [Related]
2. The future of red blood cell alloimmunization risk reduction. Karafin MS, Denomme GA, Bryant BJ. Transfusion; 2015 Jan; 55(1):220-1. PubMed ID: 25582238 [No Abstract] [Full Text] [Related]
3. Prospective antigen matching strategies fail to fit the model. Webb J, Chou ST. Transfusion; 2015 Jan; 55(1):221-2. PubMed ID: 25582239 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA. Transfusion; 2014 Jan; 54(1):86-97. PubMed ID: 23692415 [Abstract] [Full Text] [Related]
5. Red blood cell alloimmunization: lessons from sickle cell disease. Treml A, King KE. Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994 [No Abstract] [Full Text] [Related]
6. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353 [Abstract] [Full Text] [Related]
7. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Venkateswaran L, Teruya J, Bustillos C, Mahoney D, Mueller BU. Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771 [Abstract] [Full Text] [Related]
9. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [Abstract] [Full Text] [Related]
17. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion. Chonat S, Arthur CM, Zerra PE, Maier CL, Jajosky RP, Yee MEM, Miller MJ, Josephson CD, Roback JD, Fasano R, Stowell SR. Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566 [Abstract] [Full Text] [Related]
18. Relevance of blood groups in transfusion of sickle cell disease patients. Noizat-Pirenne F. C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398 [Abstract] [Full Text] [Related]
19. Red blood cell alloimmunization in sickle cell anemia: more questions than answers? Campbell-Lee SA. Transfusion; 2012 Feb; 52(2):214-6. PubMed ID: 22239207 [No Abstract] [Full Text] [Related]
20. Blood bank issues associated with red cell exchanges in sickle cell disease. Sarode R, Altuntas F. J Clin Apher; 2006 Dec; 21(4):271-3. PubMed ID: 17177280 [Abstract] [Full Text] [Related] Page: [Next] [New Search]